PRKDC and breast cancer: The authors discovered that scaRNA2 binds to DNA-PKcs through its C/D box in human breast cancer cells and osteosarcoma cells, thereby preventing the forming of a complete DNA-PK complex with KU protein and inhibiting autophosphorylation at Ser2056 and Thr2609 sites.